111 – 120 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis
(
- Contribution to journal › Article
-
Mark
Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy
(
- Contribution to journal › Article
-
Mark
3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care!
(
- Contribution to journal › Article
-
Mark
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis : the GENOMOS study
(
- Contribution to journal › Article
- 2007
-
Mark
Residual lifetime risk of fractures in women and men
(
- Contribution to journal › Article
-
Mark
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
(
- Contribution to journal › Article
- 2006
-
Mark
The association between common vitamin D receptor gene variations and osteoporosis : a participant-level meta-analysis
(
- Contribution to journal › Article
-
Mark
Physical activity and its effect on bone in the short- and long- term perspective.
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
(
- Contribution to journal › Article